SEARCH
Subscribe
Track all markets on TradingView

Biotech Stock Powers Higher on Study Update

Published:

Reading time: 3 min.

Theralase Technologies Inc. (TSXV:TLT), a biotech stock, jumped after providing an update on its Phase Ib Non-Muscle Invasive Bladder Cancer clinical study

Sean Mason | May 17, 2018 | SmallCapPower

Promising clinical study results produced a healthy gain for a biotech stock Thursday. Here’s some small stocks making big moves on Thursday, May 17, 2018 (as of 4 pm EST):

Theralase Technologies Inc. (TSXV:TLT), a biotech stock, surged 58% to $0.315 on Thursday after providing an update on the Phase Ib Non-Muscle Invasive Bladder Cancer clinical study currently in progress, in which the Company said Patient Number Six’s 90-day clinical cystoscopy assessment to rule out recurrent NMIBC has now been completed and the patient has demonstrated no clinical evidence or presence of disease.

Win Big With Our Small Cap Picks

 

As well, shares of ATS Automation Tooling Systems Inc. (TSX:ATA) gained 11% to $19.25 as the automation solutions provider said its fiscal 2018 revenue rose 10% to $1.12 billion, while earnings per share for the year was $0.50 compared with $0.38 during fiscal 2017.

International Zeolite Corp. (TSXV:IZ), meanwhile, reported that it has submitted its first order for 400 tonnes of natural zeolite from Cuba. The Company added that it has now has increased capabilities to delivery and supply zeolite markets around the world with Cuba’s support and expertise. International Zeolite stock moved up 30% to $0.37 following the announcement.

Finally, AnalytixInsight Inc. (TSXV:ALY) shares continued to move higher Thursday, up 3% to $0.495. Shares of the Artificial Intelligence company surged 33% on Wednesday after announcing that it has entered into a distribution agreement with Thomson Reuters, whereby Thomson Reuters will distribute financial research reports created by AnalytixInsight’s artificial intelligence platform to customers on its financial desktop applications Eikon and Thomson One.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
jsteppke
jsteppke

Related articles

Recent articles

© SmallCapPower 2024